Elemental Capital Partners LLC Purchases Shares of 107,140 Lam Research Co. (NASDAQ:LRCX)

Elemental Capital Partners LLC purchased a new stake in Lam Research Co. (NASDAQ:LRCX) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 107,140 shares of the semiconductor company’s stock, valued at approximately $7,739,000. Lam Research makes up approximately 7.2% of Elemental Capital Partners LLC’s investment portfolio, making the stock its 4th biggest holding.

Other hedge funds have also recently bought and sold shares of the company. Atwood & Palmer Inc. bought a new position in shares of Lam Research during the 4th quarter worth approximately $27,000. West Oak Capital LLC boosted its stake in Lam Research by 50.9% in the 4th quarter. West Oak Capital LLC now owns 400 shares of the semiconductor company’s stock valued at $29,000 after purchasing an additional 135 shares during the period. Country Trust Bank boosted its stake in Lam Research by 900.0% in the 4th quarter. Country Trust Bank now owns 400 shares of the semiconductor company’s stock valued at $29,000 after purchasing an additional 360 shares during the period. Finley Financial LLC acquired a new position in Lam Research in the 4th quarter valued at $30,000. Finally, Stephens Consulting LLC raised its holdings in Lam Research by 900.0% in the 4th quarter. Stephens Consulting LLC now owns 430 shares of the semiconductor company’s stock valued at $31,000 after acquiring an additional 387 shares in the last quarter. 84.61% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

LRCX has been the subject of a number of research analyst reports. B. Riley lowered their price target on Lam Research from $132.50 to $105.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. BNP Paribas raised Lam Research to a “hold” rating in a report on Thursday, October 24th. Barclays lowered their target price on Lam Research from $90.00 to $75.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. The Goldman Sachs Group lowered their target price on Lam Research from $96.00 to $85.00 and set a “buy” rating for the company in a report on Friday, January 10th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $100.00 target price (down previously from $105.00) on shares of Lam Research in a report on Thursday, October 24th. Seven analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $95.72.

Lam Research Stock Performance

Lam Research stock opened at $81.94 on Thursday. The company has a quick ratio of 1.73, a current ratio of 2.54 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $105.43 billion, a P/E ratio of 24.89, a PEG ratio of 1.34 and a beta of 1.46. The stock’s 50 day moving average is $76.32 and its 200 day moving average is $78.33. Lam Research Co. has a twelve month low of $68.87 and a twelve month high of $113.00.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. On average, equities research analysts predict that Lam Research Co. will post 3.69 earnings per share for the current fiscal year.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.